Literature DB >> 18023036

Minocycline and N-methyl-4-isoleucine cyclosporin (NIM811) mitigate storage/reperfusion injury after rat liver transplantation through suppression of the mitochondrial permeability transition.

Tom P Theruvath1, Zhi Zhong, Peter Pediaditakis, Venkat K Ramshesh, Robert T Currin, Andrey Tikunov, Ekhson Holmuhamedov, John J Lemasters.   

Abstract

UNLABELLED: Graft failure after liver transplantation may involve mitochondrial dysfunction. We examined whether prevention of mitochondrial injury would improve graft function. Orthotopic rat liver transplantation was performed after 18 hours' cold storage in University of Wisconsin solution and treatment with vehicle, minocycline, tetracycline, or N-methyl-4-isoleucine cyclosporin (NIM811) of explants and recipients. Serum alanine aminotransferase (ALT), necrosis, and apoptosis were assessed 6 hours after implantation. Mitochondrial polarization and cell viability were assessed by intravital microscopy. Respiration and the mitochondrial permeability transition (MPT) were assessed in isolated rat liver mitochondria. After transplantation with vehicle or tetracycline, ALT increased to 5242 U/L and 4373 U/L, respectively. Minocycline and NIM811 treatment decreased ALT to 2374 U/L and 2159 U/L, respectively (P < 0.01). Necrosis and terminal deoxynucleotidyl transferase-mediated nick-end labeling (TUNEL) also decreased from 21.4% and 21 cells/field, respectively, after vehicle to 10.1% and 6 cells/field after minocycline and to 8.7% and 5.2 cells/field after NIM811 (P < 0.05). Additionally, minocycline decreased caspase-3 activity in graft homogenates (P < 0.05). Long-term graft survival was 27% and 33%, respectively, after vehicle and tetracycline treatment, which increased to 60% and 70% after minocycline and NIM811 (P < 0.05). In isolated mitochondria, minocycline and NIM811 but not tetracycline blocked the MPT. Minocycline blocked the MPT by decreasing mitochondrial Ca(2+) uptake, whereas NIM811 blocks by interaction with cyclophilin D. Intravital microscopy showed that minocycline and NIM811 preserved mitochondrial polarization and cell viability after transplantation (P < 0.05).
CONCLUSION: Minocycline and NIM811 attenuated graft injury after rat liver transplantation and improved graft survival. Minocycline and/or NIM811 might be useful clinically in hepatic surgery and transplantation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18023036      PMCID: PMC2656601          DOI: 10.1002/hep.21912

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  42 in total

Review 1.  Apoptosis and caspases in neurodegenerative diseases.

Authors:  Robert M Friedlander
Journal:  N Engl J Med       Date:  2003-04-03       Impact factor: 91.245

2.  Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart.

Authors:  Sabzali A Javadov; Samantha Clarke; Manika Das; Elinor J Griffiths; Kelvin H H Lim; Andrew P Halestrap
Journal:  J Physiol       Date:  2003-04-11       Impact factor: 5.182

3.  Development of a new method for hepatic rearterialization in rat orthotopic liver transplantation. Reduction of liver injury and improvement of surgical outcome by arterialization.

Authors:  W Gao; J J Lemasters; R G Thurman
Journal:  Transplantation       Date:  1993-07       Impact factor: 4.939

4.  Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice.

Authors:  Shan Zhu; Irina G Stavrovskaya; Martin Drozda; Betty Y S Kim; Victor Ona; Mingwei Li; Satinder Sarang; Allen S Liu; Dean M Hartley; Du Chu Wu; Steven Gullans; Robert J Ferrante; Serge Przedborski; Bruce S Kristal; Robert M Friedlander
Journal:  Nature       Date:  2002-05-02       Impact factor: 49.962

5.  Lethal effect of the anti-Fas antibody in mice.

Authors:  J Ogasawara; R Watanabe-Fukunaga; M Adachi; A Matsuzawa; T Kasugai; Y Kitamura; N Itoh; T Suda; S Nagata
Journal:  Nature       Date:  1993-08-26       Impact factor: 49.962

Review 6.  Mitochondrial permeability transition: a common pathway to necrosis and apoptosis.

Authors:  Jae-Sung Kim; Lihua He; John J Lemasters
Journal:  Biochem Biophys Res Commun       Date:  2003-05-09       Impact factor: 3.575

Review 7.  Liver ischemia: apoptosis as a central mechanism of injury.

Authors:  Hannes A Rüdiger; Rolf Graf; Pierre-Alain Clavien
Journal:  J Invest Surg       Date:  2003 May-Jun       Impact factor: 2.533

8.  Mitochondrial permeability transition in the switch from necrotic to apoptotic cell death in ischemic rat hepatocytes.

Authors:  Jae-Sung Kim; Ting Qian; John J Lemasters
Journal:  Gastroenterology       Date:  2003-02       Impact factor: 22.682

9.  Inhibition of the mitochondrial permeability transition by the nonimmunosuppressive cyclosporin derivative NIM811.

Authors:  Peter C Waldmeier; Jean-Jacques Feldtrauer; Ting Qian; John J Lemasters
Journal:  Mol Pharmacol       Date:  2002-07       Impact factor: 4.436

10.  Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice.

Authors:  Jennifer E A Wells; R John Hurlbert; Michael G Fehlings; V Wee Yong
Journal:  Brain       Date:  2003-06-04       Impact factor: 13.501

View more
  51 in total

1.  Inhibition of the mitochondrial permeability transition by protein kinase A in rat liver mitochondria and hepatocytes.

Authors:  Peter Pediaditakis; Jae-Sung Kim; Lihua He; Xun Zhang; Lee M Graves; John J Lemasters
Journal:  Biochem J       Date:  2010-11-01       Impact factor: 3.857

2.  Inhibition of inducible nitric oxide synthase prevents graft injury after transplantation of livers from rats after cardiac death.

Authors:  Yanjun Shi; Hasibur Rehman; Gary L Wright; Zhi Zhong
Journal:  Liver Transpl       Date:  2010-11       Impact factor: 5.799

3.  Sphingosine kinase-2 inhibition improves mitochondrial function and survival after hepatic ischemia-reperfusion.

Authors:  Yanjun Shi; Hasibur Rehman; Venkat K Ramshesh; Justin Schwartz; Qinlong Liu; Yasodha Krishnasamy; Xun Zhang; John J Lemasters; Charles D Smith; Zhi Zhong
Journal:  J Hepatol       Date:  2011-07-12       Impact factor: 25.083

Review 4.  Regulation and pharmacology of the mitochondrial permeability transition pore.

Authors:  Dmitry B Zorov; Magdalena Juhaszova; Yael Yaniv; H Bradley Nuss; Su Wang; Steven J Sollott
Journal:  Cardiovasc Res       Date:  2009-05-15       Impact factor: 10.787

5.  C-Jun N-terminal kinase 2 promotes graft injury via the mitochondrial permeability transition after mouse liver transplantation.

Authors:  T P Theruvath; C Czerny; V K Ramshesh; Z Zhong; K D Chavin; J J Lemasters
Journal:  Am J Transplant       Date:  2008-07-28       Impact factor: 8.086

6.  Minocycline and doxycycline, but not other tetracycline-derived compounds, protect liver cells from chemical hypoxia and ischemia/reperfusion injury by inhibition of the mitochondrial calcium uniporter.

Authors:  Justin Schwartz; Ekhson Holmuhamedov; Xun Zhang; Gregory L Lovelace; Charles D Smith; John J Lemasters
Journal:  Toxicol Appl Pharmacol       Date:  2013-09-05       Impact factor: 4.219

7.  Cyclosporin A in left ventricular remodeling after myocardial infarction.

Authors:  Andaleb Kholmukhamedov; Christina Logdon; Jiangting Hu; Richard A McKinney; Francis G Spinale; John J Lemasters; Rupak Mukherjee
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-10-25       Impact factor: 4.733

8.  Infection with the dengue RNA virus activates TLR9 signaling in human dendritic cells.

Authors:  Jenn-Haung Lai; Mei-Yi Wang; Chuan-Yueh Huang; Chien-Hsiang Wu; Li-Feng Hung; Chia-Ying Yang; Po-Yuan Ke; Shue-Fen Luo; Shih-Jen Liu; Ling-Jun Ho
Journal:  EMBO Rep       Date:  2018-06-07       Impact factor: 8.807

9.  NIM811 (N-methyl-4-isoleucine cyclosporine), a mitochondrial permeability transition inhibitor, attenuates cholestatic liver injury but not fibrosis in mice.

Authors:  Hasibur Rehman; Venkat K Ramshesh; Tom P Theruvath; Insil Kim; Robert T Currin; Shailendra Giri; John J Lemasters; Zhi Zhong
Journal:  J Pharmacol Exp Ther       Date:  2008-09-18       Impact factor: 4.030

Review 10.  Potential therapeutic benefits of strategies directed to mitochondria.

Authors:  Amadou K S Camara; Edward J Lesnefsky; David F Stowe
Journal:  Antioxid Redox Signal       Date:  2010-08-01       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.